| Product Code: ETC10642254 | Publication Date: Apr 2025 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The India anti-epileptic drugs market import shipments showcased a gradual expansion with a modest CAGR from 2020-2024. Notably, the growth rate accelerated between 2023 and 2024, indicating increasing momentum towards the end of the period. Overall, the market exhibited a stable growth trend with a positive trajectory.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Anti-Epileptic Drugs Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Anti-Epileptic Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 India Anti-Epileptic Drugs Market - Industry Life Cycle |
3.4 India Anti-Epileptic Drugs Market - Porter's Five Forces |
3.5 India Anti-Epileptic Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Anti-Epileptic Drugs Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.7 India Anti-Epileptic Drugs Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Anti-Epileptic Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of epilepsy in India |
4.2.2 Growing awareness about epilepsy and available treatment options |
4.2.3 Rising healthcare expenditure and improving healthcare infrastructure in India |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval and marketing |
4.3.2 High cost associated with anti-epileptic drugs |
4.3.3 Limited access to healthcare services in rural areas of India |
5 India Anti-Epileptic Drugs Market Trends |
6 India Anti-Epileptic Drugs Market, By Types |
6.1 India Anti-Epileptic Drugs Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Anti-Epileptic Drugs Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 India Anti-Epileptic Drugs Market Revenues & Volume, By First-Generation Drugs, 2021 - 2031F |
6.1.4 India Anti-Epileptic Drugs Market Revenues & Volume, By Second-Generation Drugs, 2021 - 2031F |
6.1.5 India Anti-Epileptic Drugs Market Revenues & Volume, By Third-Generation Drugs, 2021 - 2031F |
6.1.6 India Anti-Epileptic Drugs Market Revenues & Volume, By Generic Drugs, 2021 - 2031F |
6.2 India Anti-Epileptic Drugs Market, By Therapy |
6.2.1 Overview and Analysis |
6.2.2 India Anti-Epileptic Drugs Market Revenues & Volume, By Monotherapy, 2021 - 2031F |
6.2.3 India Anti-Epileptic Drugs Market Revenues & Volume, By Adjunct Therapy, 2021 - 2031F |
6.2.4 India Anti-Epileptic Drugs Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.2.5 India Anti-Epileptic Drugs Market Revenues & Volume, By Epilepsy Treatment, 2021 - 2031F |
6.3 India Anti-Epileptic Drugs Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 India Anti-Epileptic Drugs Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 India Anti-Epileptic Drugs Market Revenues & Volume, By Neurology Clinics, 2021 - 2031F |
6.3.4 India Anti-Epileptic Drugs Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.3.5 India Anti-Epileptic Drugs Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
7 India Anti-Epileptic Drugs Market Import-Export Trade Statistics |
7.1 India Anti-Epileptic Drugs Market Export to Major Countries |
7.2 India Anti-Epileptic Drugs Market Imports from Major Countries |
8 India Anti-Epileptic Drugs Market Key Performance Indicators |
8.1 Number of epilepsy diagnosis cases in India |
8.2 Percentage of epilepsy patients receiving treatment with anti-epileptic drugs |
8.3 Adoption rate of newer, more effective anti-epileptic drugs |
8.4 Number of neurologists and healthcare facilities specializing in epilepsy treatment |
8.5 Patient adherence rate to prescribed anti-epileptic drug regimens |
9 India Anti-Epileptic Drugs Market - Opportunity Assessment |
9.1 India Anti-Epileptic Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Anti-Epileptic Drugs Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.3 India Anti-Epileptic Drugs Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India Anti-Epileptic Drugs Market - Competitive Landscape |
10.1 India Anti-Epileptic Drugs Market Revenue Share, By Companies, 2024 |
10.2 India Anti-Epileptic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here